ロード中...
Combination treatment with flavonoid morin and telomerase inhibitor MST-312 reduces cancer stem cell traits by targeting STAT3 and telomerase
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide. The malignant CRC that undergoes metastasis in the advanced stage is usually refractory to existing chemotherapy and shows a poor prognosis. However, to date, efficient targeted-therapy for metastatic CRC is ill-defined...
保存先:
| 出版年: | Int J Oncol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4922839/ https://ncbi.nlm.nih.gov/pubmed/27279256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2016.3546 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|